RF generators for arrhythmias market to reach $1.97 billion by 2030

The market for radiofrequency generators used in arrhythmia treatment is projected to grow from $1.26 billion in 2025 to $1.97 billion by 2030, driven by rising arrhythmia cases, more catheter ablations and wider use of minimally invasive cardiac procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Radiofrequency generators are a core tool in electrophysiology procedures that target abnormal heart rhythms. - Demand is rising as arrhythmias and atrial fibrillation become more common, especially in aging populations. - The market’s growth reflects broader adoption of minimally invasive cardiac care and more advanced ablation technologies.

What happened: - The Business Research Company projected the global radiofrequency (RF) generators for arrhythmias market at $1.26 billion in 2025. - The market is forecast to reach $1.38 billion in 2026, implying 9.7% annual growth. - The market is expected to climb to $1.97 billion by 2030 at a 9.3% CAGR. - The report is titled Radiofrequency (RF) Generators For Arrhythmias Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The company offered a free sample of the report and the full market report.

The details: - RF generators deliver controlled high-frequency electrical energy to create precise lesions in cardiac tissue. - Those lesions help correct abnormal heart rhythms by targeting the electrical source of arrhythmias. - The devices are designed for accurate energy modulation, real-time monitoring and safe tissue targeting. - Key growth drivers include higher arrhythmia prevalence, more catheter ablation procedures in hospitals, expanding electrophysiology lab infrastructure, better RF energy delivery technology and an aging population. - A major demand driver is the rise in atrial fibrillation cases. - In September 2024, the National Heart, Lung, and Blood Institute estimated about 10.55 million U.S. adults had atrial fibrillation, up from an earlier estimate of 3.3 million. - Preference for minimally invasive cardiac procedures is also lifting demand because these treatments reduce trauma and recovery time compared with open-heart surgery. - In March 2025, The Society of Thoracic Surgeons reported overall cardiac surgical volumes rose 4.2% in 2023 from 2022. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast points to a market moving from basic ablation support toward more precision-driven, software-enabled procedures. - Expected adoption of AI-assisted cardiac mapping, contact force sensing systems and high-power short-duration ablation suggests providers are pushing for faster, safer and more targeted treatment. - Growth in outpatient and ambulatory cardiac procedures could shift demand toward systems built for efficiency and shorter procedure times. - More investment in hybrid surgical-electrophysiology models and advanced minimally invasive technologies suggests hospitals are preparing for more complex arrhythmia cases.

What's next: - The report expects wider use of temperature-controlled irrigated RF generators to improve safety. - It also expects expanding electrophysiology labs to support more complex arrhythmia care. - Market growth will likely track continued innovation in mapping, navigation and ablation systems through 2030. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated trend analysis.

The bottom line: - RF generators for arrhythmia treatment remain on a strong growth path as cardiac procedures become more precise, less invasive and more technology-driven.